Irritable bowel syndrome

American Journal of Nursing

Volumn 101, Issue 1, 2001, Pages 26-33

  Heitkemper, Margaret ^a   Jarett, Monica ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL; COLON; HUMAN; IRRITABLE COLON; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; COLON; COLONIC DISEASES, FUNCTIONAL; HUMANS; SEROTONIN; SEROTONIN AGENTS;

EID: 0035229306     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200101000-00045     Document Type: Article

References (50)

1. International Foundation for Functional Gastrointestinal Disorders. About irritable bowel syndrome (IBS). 2000. http://www.aboutibs.org.
2. Glaxo Wellcome. IBS in American women: dispelling the myths [online]. http://www.glaxowellcome.co.uk/fighting/ fr_fighting.html.
3. Garnett WR. Clinical consult: management of irritable bowel syndrome [online]. J Am Soc Consultant Pharm 1999;14(Suppl 8).
4. Drossman DA, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38(9):1569-80.
5. Taub E, et al. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci 1995;40(12):2647-55.
6. Talley NJ, et al. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997;41(3):394-8.
7. Zuckerman MJ, et al. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci 1996;41(1):77-82.
8. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99(2):409-15.
9. Talley NJ, et al. Medical costs in community subjects with irritable bowel syndrome [comment]. Gastroenterology 1995;109(6):1736-41.
10. Hahn BA, et al. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997;42(12):2585-90.
11. National Center for Health Statistics. National Health Interview Survey (NHIS) [Web site]; 2000. http://www.cdc.gov/nchs/nhis.htm.
12. Blackington E. Irritable bowel syndrome: an update on treatment options. Adv Nurse Pract 2000;8(10):32-9.
13. American Gastroenterological Association. Irritable bowel syndrome [online]. 2000. http://www.gastro.org/public/ ibs.html.
14. Ternent CA. Functional bowel disorders/constipation [online]. American Society of Colon and Rectal Surgeons. 2000. http://www.fascrs.org/coresubjects/2000/ternent.html.
15. Heitkemper MM, et al. Daily gastrointestinal symptoms in women with and without a diagnosis of IBS. Dig Dis Sci 1995;40(7):1511-9.
16. Corney RH, Stanton R. Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res 1990;34(5):483-91.
17. Manning AP, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2(6138):653-4.
18. Drossman DA. Irritable bowel syndrome. Am Fam Physician 1989;39(6):159-64.
19. Thompson WG, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:1143-7.
20. Hyams JS, et al. Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1995;20(2):209-14.
21. Burke P, et al. Irritable bowel syndrome and recurrent abdominal pain. A comparative review. Psychosomatics 1999;40(4):277-85.
22. Schulman Ronca and Bucuvalas, Inc. IBS in American women: a landmark survey [executive summary]; 1999.
23. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999;107(5A):41S-50S.
24. Dill B, et al. Abuse, threat, and irritable bowel syndrome: what is the connection? Gastroenterol Nurs 1997;20(6):211-5.
25. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107(1):271-93.
26. Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther 1999;13(Suppl 2):3-14.
27. Drossman DA, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000;95(4):974-80.
28. Levy RL, et al. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000;95(2):451-6.
29. Spiller RC. Disturbances in large bowel motility. Baillieres Best Pract Res Clin Gastroenterol 1999;13(3):397-413.
30. Kellow JE, et al. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut 1999;45 Suppl 2:II17-24.
31. American Academy of Family Physicians. Family health facts: irritable bowel syndrome: tips on controlling your symptoms [online]. http://familydoctor.org/healthfacts/ 112/index.html.
32. Al-Chaer ED, et al. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000;119(5):1276-85.
33. Lembo T, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94(5):1320-6.
34. Mertz H, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109(1):40-52.
35. Cook IJ, et al. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987;93(4):727-33.
36. Whitehead WE, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98(5 Pt 1):1187-92.
37. Schmulson M, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999;94(10):2929-35.
38. Jarrett M, et al. The relationship between psychological distress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs Res 1998;47(3):154-61.
39. Walker EA, et al. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol 1996;17(1):39-46.
40. Ali A, et al. Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome. Psychosom Med 2000;62(1):76-82.
41. Boyce P, et al. Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study. Aust N Z J Psychiatry 2000;34(2):300-9.
42. Toner BB, et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychother 1998;48(2):215-43.
43. Smart HL, et al. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 1986;27(7):826-8.
44. Kumar V. A study of the therapeutic potential of some hathayogic methods in the management of irritable bowel syndrome. IAYT J Int Assoc Yoga Ther 1992;3:25-38.
45. Mauer CE Acupuncture and irritable bowel syndrome. Oriental Med J 1998;7(1):53-7.
46. Bensoussan A, et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998;280(18):1585-9.
47. Mayer EA, et al. Approaches to the modulation of abdominal pain. Can J Gastroenterol 1999;13(Suppl A):65A-70A.
48. Mangel AW, Northcutt AR. Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients. Aliment Pharmacol Ther 1999;13)(Suppl 2):77-82.
49. Prather CM, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000;118(3):463-8.
50. Farthing MJ. Irritable bowel syndrome: new pharmaceutical approaches to treatment. Baillieres Best Pract Res Clin Gastroenterol 1999;13(3):461-71.